Press Releases for MSFT

Press Releases
Haemacure's Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
Dr. Jonathan White Joins Haemonetics as Head of Research and Development
Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
Haemonetics Reports Double Digit Revenue, Operating Income, and EPS Growth for the Second Quarter Fiscal 2009
Haemonetics Sets Date for Second Quarter Fiscal Year 2009 Earnings Release and Conference Call - October 27, 2008
Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Presentation at BioContact Quebec 2008
Presentation at BioContact Quebec 2008
Haemacure to Present at the Sachs 8th Annual - Biotech in Europe Investor Forum
Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
Haemonetics Posts Investor Update
Haemacure Provides Update on Fibrin Sealant Project and Reports Third Quarter Results
Haemacure Provides Update on Fibrin Sealant Project and Reports Third Quarter Results
Haemonetics Reports Double Digit Revenue, Operating Income, and EPS Growth for the First Quarter Fiscal 2009
Haemonetics Sets Date for First Quarter Fiscal Year 2009 Earnings Release and Conference Call - August 1, 2008
Haemonetics to Present at Jefferies Investor Conference
Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
Haemonetics Announces Launch of Faster Plasma Collection Protocol
Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
Haemacure Reports on Financing Progress and Second Quarter Results
Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract
Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
Haemonetics Sets Date for Investor Meeting
Haemonetics Sets Date for Investor Meeting
Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
Haemacure appoints Reinaldo M. Diaz to its Board of Directors
Haemonetics' Chairman and CEO Adopts 10b5-1 Stock Trading Plan
Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008